NextCure Inc. (NXTC) Prices 4.077M Share Common Offering at $36.75/Sh

NextCure, Inc. (NASDAQ: NXTC) today announced the pricing of its public offering of 4,077,192 shares of its common stock at a public offering price of $36.75 per share. NextCure also granted the underwriters a 30-day option to purchase up to an additional 611,578 shares of its common stock at the public offering price less the underwriting discounts and commissions. All of the common stock to be sold in the offering are being offered by NextCure. Gross proceeds from the offering, before deducting underwriting discounts and commissions and estimated offering expenses, will be approximately $150 million, excluding any exercise of the underwriters’ option to purchase additional shares. The offering is expected to close on or about November 19, 2019, subject to the satisfaction of customary closing conditions.

Morgan Stanley, BofA Securities and Piper Jaffray & Co. are acting as joint book-running managers for the offering. Needham & Company and BTIG are acting as co-managers for the offering.

You May Also Be Interested In

• Jersey Mike's closes IPO at $23 per share on NYSE
• Axos Financial (AX) PT Raised to $128 at Needham
• Merit Medical Systems, Inc. (MMSI) PT Raised to $101 at Needham